The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays
- 1 September 2006
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 356 (1) , 157-159
- https://doi.org/10.1016/j.ab.2006.05.020
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Measurement of Procarboxypeptidase U (TAFI) in Human Plasma: A Laboratory ChallengeClinical Chemistry, 2006
- Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulationBlood, 2005
- Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrateAnalytical Biochemistry, 2005
- Carboxypeptidase N: a pleiotropic regulator of inflammationMolecular Immunology, 2003
- Mapping the Pro-region of Carboxypeptidase B by Protein EngineeringJournal of Biological Chemistry, 1999
- The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogenThe EMBO Journal, 1997
- Colorimetric assay for carboxypeptidase N in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Familial Carboxypeptidase N DeficiencyAnnals of Internal Medicine, 1980
- Isolation and characterization of pancreatic procarboxypeptidase B and carboxypeptidase B of the African lungfishBiochemistry, 1972
- An enzyme in human blood plasma that inactivates bradykinin and kallidinsBiochemical Pharmacology, 1962